Used primarily as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure allows for modification into bioactive molecules, making it valuable in medicinal chemistry for creating analogs with potential antipsychotic, antidepressant, or cognitive-enhancing effects. The compound’s trifluoromethyl group enhances metabolic stability and lipophilicity, which improves blood-brain barrier penetration—key for targeting neurological pathways. It is also employed in research settings to explore structure-activity relationships in nitrogen-containing heterocycles.